{"filing":{"accession_number":"0001193125-26-379420","cik":"0001861795","ticker":"DH","company_name":"Definitive Healthcare Corp.","form":"8-K","filing_date":"2026-09-02","report_date":"2026-08-28","primary_document":"dh-20260828.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526379420/dh-20260828.htm"},"events":[{"id":31184,"run_id":28603,"accession_number":"0001193125-26-379420","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Clay Ritchey as Chief Executive Officer and Board member, effective September 8, 2026. While the section also mentions Kevin Coop's departure as CEO, the principal disclosed action centers on the new CEO appointment with detailed employment terms including $500,000 base salary, 87.5% target bonus, and $4,000,000 in new hire equity awards. This is a material executive leadership change affecting investor assessment of company direction and governance.","company_name":"Definitive Healthcare Corp.","ticker":"DH","filing_date":"2026-09-02","form":"8-K","submitted_at":null,"items":[{"id":34002,"accession_number":"0001193125-26-379420","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Clay Ritchey as Chief Executive Officer and Board member, effective September 8, 2026. While the section also mentions Kevin Coop's departure as CEO, the principal disclosed action centers on the new CEO appointment with detailed employment terms including $500,000 base salary, 87.5% target bonus, and $4,000,000 in new hire equity awards. This is a material executive leadership change affecting investor assessment of company direction and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T12:34:56.173750+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34002,"accession_number":"0001193125-26-379420","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Clay Ritchey as Chief Executive Officer and Board member, effective September 8, 2026. While the section also mentions Kevin Coop's departure as CEO, the principal disclosed action centers on the new CEO appointment with detailed employment terms including $500,000 base salary, 87.5% target bonus, and $4,000,000 in new hire equity awards. This is a material executive leadership change affecting investor assessment of company direction and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T12:34:56.173750+00:00","company_name":"Definitive Healthcare Corp.","ticker":"DH","filing_date":"2026-09-02"}]}